Pipeline
Pipeline Under Construction.
Perago Bio is actively sourcing and evaluating preclinical therapeutic assets across CNS, immunology, oncology, and rare disease. Program details will be disclosed selectively to qualified investors and partners under NDA.
Current Status
We are in the asset identification and early diligence phase. Initial programs are being evaluated against our standardized screening matrix. No public program disclosures at this time.
Confidential — NDA Required
Program names, indications, mechanisms, and stage detail are available to qualified investors and asset partners under mutual NDA. Contact us to request the full pipeline briefing.
Therapeutic Focus Areas
Active Sourcing
CNS / Neurology
Active Sourcing
Immunology / Inflammation
Active Sourcing
Oncology
Active Sourcing
Rare Disease
Asset Holders & Investors
If you represent an academic institution, early-stage biotech, or pharma divestiture with a preclinical asset that may fit our criteria — or if you are an investor seeking pipeline detail — please reach out directly.